Randomized trial explores biochemical and mechanical signals in liver cirrhosis and HCC, suggesting a new therapeutic direction.
Traditional hepatology conceptualizes liver cirrhosis as the linear accumulation of extracellular matrix (ECM). However, the stagnation of fibrosis reversal and the persistent risk of hepatocellular carcinoma (HCC) despite eradication of the etiology remain significant clinical challenges. We propose the “Chronological Decoupling” hypothesis: cirrhosis arises from a specific temporal mismatch (Δ t > physiological resolution window of 7–14 days) between Signal A (biochemical clearance, defined as >50% shift of macrophages to TREM2+ restorative phenotype with MMP-9/MMP-13 secretion) and Signal B (mechanical regeneration, defined as Piezo1-mediated YAP nuclear translocation >50% in hepatocytes under lateral crowding pressure). In chronic injury, Signal B is triggered prematurely before Signal A completes, producing “Chaotic Deconstruction” quantifiable as increased ECM fragment heterogeneity, secondary inflammation markers, and covalent cross-linking via LOXL2 . This creates an immune-excluded oncogenic niche. We shift therapeutic focus from continuous anti-fibrotics to “Protocol Resynchronization,” a biomarker-timed sequential therapy.
No takes yet. Share an insight, caveat, or question.
Y L Li (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: